Epstein-Barr virus related opsoclonus-myoclonus-ataxia does not rule out the presence of occult neuroblastic tumors

Pediatric Blood and Cancer

Volumn 47, Issue 7, 2006, Pages 964-967

  Cardesa Salzmann, Teresa M ^a   Mora, Jaume ^a   García Cazorla, M Angels ^a   Cruz, Ofelia ^a   Muñoz, Carmen ^a   Campistol, Jaume ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Epstein Barr virus; Neuroblastic tumors; Opsoclonus myoclonus ataxia

Indexed keywords

CORTICOTROPIN; FERRITIN; HOMOVANILLIC ACID; IMMUNOGLOBULIN G ANTIBODY; LACTATE DEHYDROGENASE; NEURON SPECIFIC ENOLASE; VANILMANDELIC ACID;

ARTICLE; ATAXIA; CASE REPORT; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; HUMAN; MALE; MICROBIOLOGICAL EXAMINATION; MYOCLONUS; NEUROBLASTOMA; OCCULT CANCER; OPSOCLONUS; OPSOCLONUS MYOCLONUS ATAXIA SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; THORAX TUMOR; VIRUS INFECTION;

EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GANGLIONEUROBLASTOMA; HUMANS; INFANT; OPSOCLONUS-MYOCLONUS SYNDROME; THORACIC NEOPLASMS;

EID: 33750479046     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20573     Document Type: Article

References (10)

1. Prazantelli M. The neurobiology of the opsoclonus myoclonus syndrome. Clin Neuropharmacol 1992;15:186-228.
2. Sheth RD, Horowitz SJ, Aronoff S, et al. Opsoclonus myoclonus syndrome secondary to Epstein-Barr virus infection. J Child Neurol 1995;10:297-299.
3. Verma A, Brozman B. Opsoclonus-myoclonus syndrome following Epstein-Barr virus infection. Neurol 2002;58:1131-1132.
4. Rudnick E, Khakoo Y, Antunes NL, et al. Opsoclonus-myoclonusataxia syndrome in neuroblastoma: Clinical outcome and antineuronal antibodies-A report from the children's cancer group. Med Pediatr Oncol 2001;36:612-622.
5. Hiyama E, Yokohama T, Ichikawa T, et al. Poor outcome in patients with advanced stage neuroblastoma and coincident opsoclonus-myoclonus syndrome. Cancer 1994;74:1821-1826.
6. Yoneda A, Oue T, Imura K, et al. Observation of untreated patients with neuroblastoma detected by mass screening: A "wait and see" pilot study. Med Pediatr Oncol 2001;36:160-162.
7. Prazantelli MR. the proposed role of neurotransmitter receptors in the pathophysiology of human myoclonic disorders. Med Hypotheses 1989;30:55-60.
8. Cooper R, Khakoo Y, Matthay KK, et al. Opsoclonus-myoclonusataxia syndrome in neuroblastoma: Histopathologic features-A report from the children's cancer group. Med Pediatr Oncol 2001;36:623-629.
9. Connolly A, Pestronk A, Mehta S, et al. Serum autoantibodies in childhood opsoclonus-myoclonus syndrome: An analysis of antigenic targets in neural tissues. J Pediatr 1997;130:878-884.
10. Antunes NL, Khakoo Y, Matthay KK, et al. Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonus. J Pediatr Hematol Oncol 2000;22:315-320.